These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35524397)

  • 1. Placental dysfunction screening and perinatal loss.
    Liu B; Frick A; Bhide A; Thilaganathan B
    BJOG; 2022 Aug; 129(9):1617-1618. PubMed ID: 35524397
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal growth retardation with abnormal blood flows and placental sonographic lesions.
    Jauniaux E; Campbell S
    J Clin Ultrasound; 1990; 18(3):210-4. PubMed ID: 2155944
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.
    Aurioles-Garibay A; Hernandez-Andrade E; Romero R; Qureshi F; Ahn H; Jacques SM; Garcia M; Yeo L; Hassan SS
    Fetal Diagn Ther; 2014; 36(2):154-61. PubMed ID: 24852332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
    Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
    Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
    Kullander S; Marsál K; Persson PH
    Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
    [No Abstract]   [Full Text] [Related]  

  • 6. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
    Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
    Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Customized birth-weight centiles and placenta-related fetal growth restriction.
    Melamed N; Hiersch L; Aviram A; Keating S; Kingdom JC
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):409-416. PubMed ID: 33073889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal thrombotic vasculopathy accompanied by fetal growth restriction.
    Kim TH; Lee HH; Chung SH; Park J; Kwak JJ
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):643-5. PubMed ID: 23796264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of placental function with the placenta insufficiency score].
    Gitsch E; Philipp K
    Gynakol Rundsch; 1984; 24(3):133-9. PubMed ID: 6479690
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive Subchorionic Placental Cyst and Poor Fetal Growth: A Case Report.
    Boulis TS; Rochelson BL; Williamson AK
    J Reprod Med; 2015; 60(9-10):458-60. PubMed ID: 26592078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and treatment problems of placental insufficiency in fetal growth retardation].
    Vikhliaeva EM; Khodzhaeva ZS
    Akush Ginekol (Mosk); 1984 Jun; (6):18-24. PubMed ID: 6476241
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between placental perfusion and endocrine parameters of pregnants in cases of intrauterine growth retardation.
    Doszpod J; Csákány MG; Török M; Gáti I
    Acta Paediatr Hung; 1983; 24(4):355-60. PubMed ID: 6673737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction.
    Blitz MJ; Rochelson B; Vohra N
    Clin Lab Med; 2016 Jun; 36(2):353-67. PubMed ID: 27235917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention?
    Cuckle H; von Dadelszen P; Ghidini A
    Prenat Diagn; 2013 Jan; 33(1):17-20. PubMed ID: 23172587
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of Doppler blood flow measurement in recognizing placental insufficiency].
    Vetter K
    Arch Gynecol Obstet; 1988; 244 Suppl():S12-8. PubMed ID: 3063214
    [No Abstract]   [Full Text] [Related]  

  • 17. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral rheography versus Doppler flow measurement: competing procedures in the early detection of placental insufficiency?].
    Feiks A; Rudelstorfer R; Deutinger J; Chalubinski K; Nowotny C; Gruber W
    Gynakol Rundsch; 1989; 29 Suppl 2():288-90. PubMed ID: 2693249
    [No Abstract]   [Full Text] [Related]  

  • 19. Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight.
    Hendrix MLE; Bons JAP; Alers NO; Severens-Rijvers CAH; Spaanderman MEA; Al-Nasiry S
    Placenta; 2019 Nov; 87():8-15. PubMed ID: 31520871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects of the laboratory diagnosis of intrauterine foetal distress.
    Donát J; Jirkalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):569-622. PubMed ID: 6972081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.